Search - tctmd.com

Displaying 161 - 180 of 329

Sort: Relevancy | Date

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Michael O'Riordan

May 11, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

L.A. McKeown

April 07, 2021

News Daily News

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

Caitlin E. Cox

March 24, 2021

News Daily News

INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose

L.A. McKeown

March 19, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Todd Neale

November 17, 2020

Advertisement

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

FDA Approves Dapagliflozin for CKD Patients

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

February 2021 News Roundup

FDA Approves Vericiguat for High-risk Patients With HF

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content